Rnh1tm2.1Rall
Targeted Allele Detail
|
Symbol: |
Rnh1tm2.1Rall |
Name: |
ribonuclease/angiogenin inhibitor 1; targeted mutation 2.1, Ramanjaneyulu Allam |
MGI ID: |
MGI:7407148 |
Synonyms: |
Rnh1fl |
Gene: |
Rnh1 Location: Chr7:140740239-140752764 bp, - strand Genetic Position: Chr7, 86.44 cM
|
Alliance: |
Rnh1tm2.1Rall page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:331827
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
C57BL/6
|
|
Allele Type: |
|
Targeted (Conditional ready) |
Mutation: |
|
Insertion
|
|
|
Mutation details: A loxP site was inserted downstream of exon 10 and an FRT-flanked neomycin selection cassette and second loxP site were inserted upstream of exon 3. The neomycin cassette was removed via flp-mediated recombination in ES cells which express the flp recombinase, leaving exons 3-10 floxed.
(J:331827)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Rnh1 Mutation: |
25 strains or lines available
|
|
Original: |
J:331827 Bombaci G, et al., LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity. Life Sci Alliance. 2022 Jun;5(6):e202101226 |
All: |
1 reference(s) |
|